Primo Chemicals Q1 FY27: consolidated PAT +15% YoY as margins expand on flat revenue

Primo Chemicals reported consolidated revenue from operations of ₹140.28 Cr for Q1 FY27, down 1.2% YoY from ₹141.94 Cr and down 3.2% QoQ from ₹144.86 Cr — a broadly flat topline rather than a growth quarter. Consolidated net profit (after the associate-profit line) came in at ₹4.68 Cr, up 14.9% YoY from ₹4.08 Cr, though down 22.9% QoQ from ₹6.07 Cr in Q4 FY26 — the QoQ dip reflects a high base against a stronger prior quarter and should not be read as deterioration, since YoY the company grew profit well ahead of its (flat) revenue. The profit growth was margin-led: operating margin (EBITDA/revenue) expanded to 14.83% from 14.37% a year ago and from 13.14% in Q4 FY26, helped by contained materials and power costs (cost of materials consumed was ₹82.96 Cr versus ₹85.27 Cr a year ago on similar revenue). Net profit margin was 3.22%, up from 2.77% YoY but down from 4.04% QoQ. There were no exceptional items in either the current or year-ago quarter, so the YoY profit growth is entirely underlying, with no one-off adjustment required. Standalone and consolidated results are near-identical at the operating level — revenue, total expenses and PBT of ₹8.86 Cr are the same in both statements — because Primo holds only a 49% stake in Flow Tech Chemicals and equity-accounts it as an associate rather than fully consolidating it. That associate contributed ₹1.04 Cr to consolidated PAT this quarter, which is why consolidated PAT (₹4.68 Cr) runs about 29% above standalone PAT (₹3.64 Cr) — a divergence worth flagging since readers will see the standalone number too. This relationship is in transition: the board approved (July 2, 2026) and shareholders cleared (August 5, 2026) converting the 49% stake into a controlling 51%+ stake, making Flow Tech Chemicals a wholly owned subsidiary; the company notes the paperwork was still being executed as of this filing, after which Flow Tech's financials would likely be line-item consolidated rather than appearing as a single associate-profit line. Management gives no formal guidance or outlook commentary in this filing, and our records show no prior guidance or concall read to check this result against. A web search for analyst previews or consensus estimates for Primo Chemicals returned no relevant coverage, consistent with this being a lightly-tracked small-cap; vsStreet is marked unknown rather than guessed. Other Q1 developments in our event records — the May 2026 ₹21 Cr solar power plant investment and routine insider-trading window/share-transfer disclosures — are not separately broken out in this result and show no discernible P&L impact this quarter.